002432 九安医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)--6.454142.95638.20013.660
总资产报酬率 ROA (%)--5.644124.93828.44411.018
投入资产回报率 ROIC (%)--5.873131.51231.02110.359

边际利润分析
销售毛利率 (%)70.22063.58679.60463.47556.307
营业利润率 (%)62.38449.93669.58641.82311.880
息税前利润/营业总收入 (%)62.77442.73568.58641.81012.873
净利润/营业总收入 (%)51.89241.75762.64138.98111.792

收益指标分析
经营活动净收益/利润总额(%)52.72566.113103.41194.976181.590
价值变动净收益/利润总额(%)48.29455.053-1.2767.610-7.677
营业外收支净额/利润总额(%)-0.068-2.097-0.296-0.2920.486

偿债能力分析
流动比率 (X)--7.90116.5192.7543.356
速动比率 (X)--7.71515.6462.1502.793
资产负债率 (%)--12.3567.85027.83825.873
带息债务/全部投入资本 (%)--7.2951.71717.719--
股东权益/带息债务 (%)--1,209.0455,470.912455.452465.035
股东权益/负债合计 (%)--688.0641,146.241262.542296.303
利息保障倍数 (X)145.344-6.921-86.296385.20213.764

营运能力分析
应收账款周转天数 (天)0.00028.3986.71254.9430.000
存货周转天数 (天)0.000150.00544.451186.8930.000